10x Genomics, Inc. (TXG) stock
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$54.99−3.20 (-5.50%)
Close on Nov 16, 2026Market cap $7.16BP/E –Yield –
10x Genomics operating margin
Operating margin is operating income as a percentage of revenue.
10x Genomics's operating margin for the twelve months ending Sep 30, 2026 was -11.7%. For fiscal 2025 it was -9.5%, against -31.9% the year before. The highest annual figure on record is -9.5% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9.5% | +22.4 |
| FY2024 | Dec 31, 2024 | -31.9% | +11.0 |
| FY2023 | Dec 31, 2023 | -42.9% | −10.4 |
| FY2022 | Dec 31, 2022 | -32.5% | −21.9 |
| FY2021 | Dec 31, 2021 | -10.7% | +168.1 |
| FY2020 | Dec 31, 2020 | -178.7% | −166.3 |
| FY2019 | Dec 31, 2019 | -12.4% | +63.3 |
| FY2018 | Dec 31, 2018 | -75.7% | −49.9 |
| FY2017 | Dec 31, 2017 | -25.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -10.7% | +11.0 |
| Q2 FY2026 | Jun 30, 2026 | -12.9% | −30.4 |
| Q1 FY2026 | Mar 31, 2026 | -11.3% | +14.1 |
| Q4 FY2025 | Dec 31, 2025 | -11.8% | +18.4 |
| Q3 FY2025 | Sep 30, 2025 | -21.6% | +5.7 |
| Q2 FY2025 | Jun 30, 2025 | 17.4% | +44.7 |
| Q1 FY2025 | Mar 31, 2025 | -25.4% | +18.2 |
| Q4 FY2024 | Dec 31, 2024 | -30.2% | −0.2 |
| Q3 FY2024 | Sep 30, 2024 | -27.4% | +34.3 |
| Q2 FY2024 | Jun 30, 2024 | -27.3% | +15.9 |
| Q1 FY2024 | Mar 31, 2024 | -43.6% | −4.9 |
| Q4 FY2023 | Dec 31, 2023 | -30.0% | −15.2 |
| Q3 FY2023 | Sep 30, 2023 | -61.7% | −31.2 |
| Q2 FY2023 | Jun 30, 2023 | -43.2% | +11.9 |
| Q1 FY2023 | Mar 31, 2023 | -38.7% | −2.3 |
| Q4 FY2022 | Dec 31, 2022 | -14.8% | −3.8 |
| Q3 FY2022 | Sep 30, 2022 | -30.5% | −17.8 |
| Q2 FY2022 | Jun 30, 2022 | -55.1% | −46.2 |
| Q1 FY2022 | Mar 31, 2022 | -36.5% | −26.8 |
| Q4 FY2021 | Dec 31, 2021 | -11.0% | +354.0 |
| Q3 FY2021 | Sep 30, 2021 | -12.7% | +78.2 |
| Q2 FY2021 | Jun 30, 2021 | -8.9% | +83.0 |
| Q1 FY2021 | Mar 31, 2021 | -9.7% | +18.0 |
| Q4 FY2020 | Dec 31, 2020 | -365.0% | −354.3 |
| Q3 FY2020 | Sep 30, 2020 | -90.9% | −76.0 |
| Q2 FY2020 | Jun 30, 2020 | -91.9% | −73.3 |
| Q1 FY2020 | Mar 31, 2020 | -27.7% | −22.0 |
| Q4 FY2019 | Dec 31, 2019 | -10.7% | +137.6 |
| Q3 FY2019 | Sep 30, 2019 | -14.9% | +25.9 |
| Q2 FY2019 | Jun 30, 2019 | -18.6% | – |
| Q1 FY2019 | Mar 31, 2019 | -5.7% | – |
| Q4 FY2018 | Dec 31, 2018 | -148.3% | – |
| Q3 FY2018 | Sep 30, 2018 | -40.8% | – |
See a number that looks wrong?